JP2018533976A5 - - Google Patents

Download PDF

Info

Publication number
JP2018533976A5
JP2018533976A5 JP2018536695A JP2018536695A JP2018533976A5 JP 2018533976 A5 JP2018533976 A5 JP 2018533976A5 JP 2018536695 A JP2018536695 A JP 2018536695A JP 2018536695 A JP2018536695 A JP 2018536695A JP 2018533976 A5 JP2018533976 A5 JP 2018533976A5
Authority
JP
Japan
Prior art keywords
vector
subunit
item
hglyra1
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018536695A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018533976A (ja
JP7097070B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/054199 external-priority patent/WO2017058926A1/en
Publication of JP2018533976A publication Critical patent/JP2018533976A/ja
Publication of JP2018533976A5 publication Critical patent/JP2018533976A5/ja
Application granted granted Critical
Publication of JP7097070B2 publication Critical patent/JP7097070B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018536695A 2015-10-01 2016-09-28 クロライドチャネルの標的発現及びその使用方法 Active JP7097070B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201562235914P 2015-10-01 2015-10-01
US201562235920P 2015-10-01 2015-10-01
US62/235,920 2015-10-01
US62/235,914 2015-10-01
US201662303907P 2016-03-04 2016-03-04
US62/303,907 2016-03-04
US201662378509P 2016-08-23 2016-08-23
US62/378,509 2016-08-23
PCT/US2016/054199 WO2017058926A1 (en) 2015-10-01 2016-09-28 Targeted expression of chloride channels and methods of use thereof

Publications (3)

Publication Number Publication Date
JP2018533976A JP2018533976A (ja) 2018-11-22
JP2018533976A5 true JP2018533976A5 (OSRAM) 2019-10-31
JP7097070B2 JP7097070B2 (ja) 2022-07-07

Family

ID=58427328

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018536695A Active JP7097070B2 (ja) 2015-10-01 2016-09-28 クロライドチャネルの標的発現及びその使用方法

Country Status (11)

Country Link
US (1) US11407812B2 (OSRAM)
EP (1) EP3355938B1 (OSRAM)
JP (1) JP7097070B2 (OSRAM)
KR (2) KR20250012721A (OSRAM)
CN (1) CN108289965A (OSRAM)
AU (1) AU2016332847B2 (OSRAM)
BR (1) BR112018006480A2 (OSRAM)
CA (1) CA2999279A1 (OSRAM)
HK (1) HK1252915A1 (OSRAM)
SG (1) SG10201912703PA (OSRAM)
WO (1) WO2017058926A1 (OSRAM)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019378036B2 (en) 2018-11-14 2026-05-07 Flagship Pioneering Innovations V, Inc Compositions and methods for compartment-specific cargo delivery
CA3120082A1 (en) * 2018-11-14 2020-05-22 Flagship Pioneering Innovations V, Inc. Fusosome compositions for cns delivery
CN110679548B (zh) * 2019-10-24 2021-11-30 南方医科大学南方医院 一种自闭症小鼠模型的构建方法
CN114214396A (zh) * 2020-06-30 2022-03-22 宁波市康宁医院(宁波市精神疾病预防控制中心、宁波市微循环与莨菪类药研究所) Gabrd甲基化作为抗海洛因复吸靶点的应用
CN115480485B (zh) * 2022-09-14 2024-09-10 南开大学 一种基于数据驱动模型的软镜扭转运动安全控制方法
GB202401492D0 (en) 2024-02-05 2024-03-20 Ucl Business Ltd Chloride channels and uses thereof
CN119331917B (zh) * 2024-10-28 2025-10-17 北京爱思益普生物科技股份有限公司 能够表达GlyR α1/β型GlyR的细胞株及其制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3644643A (en) * 1969-10-13 1972-02-22 Unimed Inc Method of reducing intraocular pressure using glycine
US4559157A (en) 1983-04-21 1985-12-17 Creative Products Resource Associates, Ltd. Cosmetic applicator useful for skin moisturizing
LU84979A1 (fr) 1983-08-30 1985-04-24 Oreal Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
US4873192A (en) 1987-02-17 1989-10-10 The United States Of America As Represented By The Department Of Health And Human Services Process for site specific mutagenesis without phenotypic selection
US4820508A (en) 1987-06-23 1989-04-11 Neutrogena Corporation Skin protective composition
US4992478A (en) 1988-04-04 1991-02-12 Warner-Lambert Company Antiinflammatory skin moisturizing composition and method of preparing same
US5527703A (en) 1994-05-25 1996-06-18 Merck & Co., Inc. DNA encoding glutamate gated chloride channels
US6156303A (en) 1997-06-11 2000-12-05 University Of Washington Adeno-associated virus (AAV) isolates and AAV vectors derived therefrom
US6464986B1 (en) 2000-04-14 2002-10-15 Allegan Sales, Inc. Method for treating pain by peripheral administration of a neurotoxin
NZ522888A (en) 2000-06-20 2005-01-28 Bionomics Ltd Mutations in the gamma aminobutyric acid type A receptor subunit ( GABA A ) associated with epilepsy
CA2438386A1 (en) * 2001-02-16 2002-08-29 Bristol-Myers Squibb Company Polynucleotides encoding a novel glycine receptor alpha subunit expressed in the gastrointestinal tract, hgra4, and splice variant thereof
US20040058313A1 (en) 2002-04-24 2004-03-25 Abreu Marcio Marc Compositions, targets, methods and devices for the therapy of ocular and periocular disorders
WO2007127428A2 (en) * 2006-04-28 2007-11-08 University Of Florida Research Foundation, Inc. Double-stranded/self-complementary vectors with a truncated cba promoter and methods of gene delivery
EP2061891B1 (en) 2006-08-24 2012-04-11 Virovek, Inc. Expression in insect cells of genes with overlapping open reading frames, methods and compositions therefor
WO2008143875A1 (en) 2007-05-14 2008-11-27 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Targeted delivery of glycine receptors to excitable cells
EP2058401A1 (en) * 2007-10-05 2009-05-13 Genethon Widespread gene delivery to motor neurons using peripheral injection of AAV vectors
WO2009133191A1 (en) 2008-04-30 2009-11-05 Dublin City University Compositions and methods for expressing in-frame multimeric proteins
WO2010042799A2 (en) 2008-10-09 2010-04-15 Howard Hughes Medical Institute Novel chimeric ligand-gated ion channels and methods of use thereof
WO2011137210A2 (en) 2010-04-30 2011-11-03 The Regents Of The University Of California Modulating compliance of trabecular meshwork
TW201306825A (zh) 2011-05-11 2013-02-16 Kirax Corp 狀況治療之改良套裝
JP2015527889A (ja) 2012-07-25 2015-09-24 ザ ブロード インスティテュート, インコーポレイテッド 誘導可能なdna結合タンパク質およびゲノム撹乱ツール、ならびにそれらの適用
EP2692868A1 (en) 2012-08-02 2014-02-05 Universitat Autònoma De Barcelona Adeno-associated viral (AAV) vectors useful for transducing adipose tissue
US9624288B2 (en) 2012-12-10 2017-04-18 University of Pittsburgh—of the Commonwealth System of Higher Education Engineered receptors and their use
JP2017501834A (ja) 2014-01-08 2017-01-19 サーキット セラピューティクス, インコーポレイテッド 高眼圧症の治療管理のための方法
WO2015149033A1 (en) 2014-03-27 2015-10-01 Circuit Therapeutics, Inc. System and method for therapeutic management of cough
WO2016055437A1 (en) 2014-10-06 2016-04-14 Arthrogen B.V. Aav-based gene therapy
JP2018531926A (ja) 2015-09-17 2018-11-01 コーダ バイオセラピューティクス, インコーポレイテッド 神経学的障害を処置するための組成物および方法
GB2547179A (en) 2015-10-26 2017-08-16 Quethera Ltd Genetic construct
AU2017254652B2 (en) 2016-04-21 2022-12-01 Virovek, Inc. AAV production in insect cells, methods and compositions therefor

Similar Documents

Publication Publication Date Title
US20220331409A1 (en) Factor ix gene therapy
JP7607007B2 (ja) 変異aav、及び、細胞、臓器並びに組織への遺伝子導入のための組成物、方法並びに使用法
KR102527259B1 (ko) 스터퍼/필러 폴리누클레오티드 서열을 포함하는 벡터 및 사용 방법
KR102057540B1 (ko) 세포, 기관 및 조직으로의 유전자 전이를 위한 aav 벡터 조성물 및 방법
US12246072B2 (en) Gene therapy for the treatment of CNGB1-linked retinitis pigmentosa
CN107002096A (zh) 基于aav的基因疗法
JP7558535B2 (ja) アルデヒドデヒドロゲナーゼ欠損症の治療のための遺伝子治療
CN120324641A (zh) 用于治疗达农病的基因治疗载体
CN104936606A (zh) 糖原贮积病的基因疗法
JP2023534037A5 (OSRAM)
JP2021533801A5 (OSRAM)
JP2021520811A (ja) ヘキソサミニダーゼアルファおよびベータサブユニットをコードしているバイシストロニックaavベクターならびにその使用
EP3740244B1 (en) Adeno-associated virus gene therapy for 21-hydroxylase deficiency
JP7860176B2 (ja) 変異aav、及び、細胞、臓器並びに組織への遺伝子導入のための組成物、方法並びに使用法
RU2837753C2 (ru) Вариант aav, композиции и способы, в которых он используется, а также способы его применения для переноса генов в клетки, органы и ткани
WO2023156530A1 (en) Gene therapy for neurodegenerative diseases
KR20240052746A (ko) Kcnv2 유전자 요법
Gregorevic et al. Functional enhancement of skeletal muscle by gene transfer
BR112016001210B1 (pt) Partículas de aav recombinates, e composição farmacêutica
BR112017027956B1 (pt) Vetores de vírus adenoassociado recombinante, uso e método de produção dos mesmos, e composição farmacêutica